NCT01700985View on ClinicalTrials.gov

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

March 31, 2013

Conditions
PsoriasisPlaque Psoriasis
Interventions
DRUG

122-0551

Applied twice daily for two weeks

DRUG

Vehicle

Applied twice daily for two weeks

Trial Locations (2)

78759

DermResearch, Inc., Austin

92123

Therapeutics Clinical Research, San Diego

All Listed Sponsors
lead

Therapeutics, Inc.

INDUSTRY

NCT01700985 - A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis | Biotech Hunter | Biotech Hunter